Phase III Clinical Study of YP-18 in Intra-Abdominal Infections
Latest Information Update: 27 May 2016
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Intra-abdominal infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 27 May 2016 New trial record